Telehealth Enhanced Asthma Management



Status:Recruiting
Conditions:Asthma
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:6 - 18
Updated:4/17/2018
Start Date:March 6, 2018
End Date:January 2020
Contact:Tamara T. Perry, MD
Email:perrytamarat@uams.edu
Phone:501-364-1060

Use our guide to learn which trials are right for you!

This study will conduct a 12-month randomized trial with 84 pediatric patients (aged 6-18
years) with persistent asthma to compare outcomes among patients with follow-up visits
managed via telemedicine (TM) vs. in-person (IP) visits.

The overarching hypothesis is that utilization of TM for asthma follow-up will result in
improved clinical outcomes such as Asthma Control Test (ACT) scores, lung function and
medication adherence compared to participants receiving IP follow-up care. The Investigator
also hypothesize that TM follow-up will result in higher caregiver satisfaction because
families will be able to receive quality subspecialty care in their community (TM) compared
to those who travel a distance to receive care (IP).

Inclusion Criteria:

1. age ≥6- and ≤18 years

2. persistent asthma as defined by national guidelines standards

3. receives care at an ACH asthma subspecialty clinic

4. reside ≤1.5 hour drive from Jonesboro, Springdale, Texarkana, or Fort Smith, AR

Exclusion Criteria:

1. Significant underlying respiratory disease other than asthma, such as cystic fibrosis

2. significant co-morbid conditions, such as individuals with developmental or physical
impairments that could interfere with the ability to communicate via interactive video

3. current smoker

4. severe asthma exacerbation requiring intubation in the past 12 months

5. no access to a smartphone or internet
We found this trial at
1
site
Little Rock, Arkansas 72202
Principal Investigator: Tamara T. Perry, M.D.
Phone: 501-364-1538
?
mi
from
Little Rock, AR
Click here to add this to my saved trials